Expression of the hypoxia marker carbonic anhydrase IX is critically dependent on SP1 activity. Identification of a novel type of hypoxia-responsive enhancer

Cancer Research

Volumn 63, Issue 5, 2003, Pages 917-922

  Kaluz, Stefan ^a,b   Kaluzová, Milota ^a,b   Stanbridge, Eric J ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INSTITUTE OF VIROLOGY   (Slovakia)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE IX; MITHRAMYCIN; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CANCER CELL CULTURE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; DOSE RESPONSE; ENZYME ACTIVITY; FIBROSARCOMA; HELA CELL; HUMAN; HUMAN CELL; HYPOXIA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

ANTIGENS, NEOPLASM; BINDING SITES; CARBONIC ANHYDRASES; CELL HYPOXIA; FIBROSARCOMA; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; NEOPLASM PROTEINS; PEPTIDE FRAGMENTS; PROMOTER REGIONS (GENETICS); SP1 TRANSCRIPTION FACTOR; TRANS-ACTIVATION (GENETICS); TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0037374179     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Loncaster, J. A., Harris, A. L., Davidson, S. E., Logue, J. P., Hunter, R. D., Wykoff, C. C., Pastorek, J., Ratcliffe, P. J., Stratford, I. J., and West, C. M. L. Carbonic anhydrase (CAIX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res., 61: 6394-6399, 2001.
2. Ivanov, S., Liao, S. Y., Ivanova, A., Danilkovitch-Miagkova, A., Tarasova, N., Weirich, G., Merril, M. J., Proescholdt, M. A., Oldfield, E. H., Lee, J., Zavada, J., Waheed, A., Sly, W., Lerman, M. I., and Stanbridge, E. J. Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. Am. J. Pathol., 158: 905-919, 2001.
3. Závada, J., Závadová, Z., Pastoreková, S., Ciampor, F., Pastorek, J., and Zelník, V. Expression of MaTu-MN protein in human tumor cultures and in clinical specimens. Int. J. Cancer, 54: 268-274, 1993.
4. Wykoff, C. C., Beasley, N. J., Watson, P. H., Turner, K. J., Pastorek, J., Sibtain, A., Wilson, G. D., Turley, H., Talks, K. L., Maxwell, P. H., Pugh, C. W., Ratcliffe, P. J., and Harris, A. L. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res., 60: 7075-7083, 2000.
5. 2 tension. Proc. Natl. Acad. Sci. USA, 92: 5510-5514, 1995.
6. Maxwell, P., Dachs, G. U., Gleadle, J. M., Nicholls, L. G., Harris, A. L., Stratford, I. J., Hankinson, O., Pugh, C. W., and Ratcliffe, P. J. Hypoxia inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc. Natl. Acad. Sci. USA, 94: 8104-8109, 1997.
7. Maxwell, P. H., Wiesener, M., Chang, G-W., Clifford, S., Vaux, E., Cockman, M., Wykoff, C. C., Pugh, C., Maher, E., and Ratcliffe, P. J. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature (Lond.), 399: 271-275, 1999.
8. Kaluz, S., Kaluzová, M., Chrastina, A., Olive, P. L., Pastoreková, S., Pastorek, J. Lerman, M. I., and Stanbridge, E. J. Lowered oxygen tension induces expression of the hypoxia marker MN/Carbonic anhydrase IX in the absence of hypoxia-inducible factor 1α stabilization: a role for phosphatidylinositol 3′-kinase. Cancer Res., 62: 4469-4477, 2002.
9. Olive, P. L., Aquino-Parsons, C., MacPhail, S. H., Liao, S-Y., Raleigh, J. A., Lerman, M. I., and Stanbridge, E. J. Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer. Cancer Res., 61: 8924-8929, 2001.
10. Stroka, D. M., Burkhardt, T., Desbaillets, I., Wenger, R. H., Neil, D. A. H., Bauer, C., Gassmann, M., and Candinas, D. HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. FASEB J., 15: 2445-2453, 2001.
11. Zhong, H., Agani, F., Baccala, A. A., Laughner, E., Rioseco-Camacho, N., Isaacs, W. B., Simons, J. W., and Semenza, G. L. Increased expression of hypoxia inducible factor-1α in rat and human prostate cancer. Cancer Res., 58: 5280-5284, 1998.
12. Kaluz, S., Kaluzová, M., Opavský, R., Pastoreková, S., Gibadulinová, A., Dequiedt, F., Kettmann, R., and Pastorek, J. Transcriptional regulation of the MN/CA 9 gene coding for the tumor-associated carbonic anhydrase IX. Identification and characterization of a proximal silencer element. J. Biol. Chem., 274: 32588-32595, 1999.
13. Kaluzová, M., Pastoreková, S., Svastová, E., Pastorek, J., Stanbridge, E. J., and Kaluz, S. Characterization of the MN/CA 9 promoter proximal region: a role for SP and AP1 factors. Biochem. J., 359: 669-677, 2001.
14. Pugh, C. W., Ebert, B. L., Ebrahim, O., and Ratcliffe, P. J. Characterisation of functional domains within the mouse erythropoietin 3′ enhancer conveying oxygen-regulated responses in different cell lines. Biochim. Biophys. Acta, 1217: 297-306, 1994.
15. Ebert, B. L., and Bunn, H. F. Regulation of transcription by hypoxia requires a multiprotein complex that includes hypoxia-inducible factor 1, an adjacent transcription factor, and p300/CREB binding protein. Mol. Cell Biol., 18: 4089-4096, 1998.
16. Firth, J. D., Ebert, B. L., and Ratcliffe, P. J. Hypoxic regulation of lactate dehydrogenase A: interaction between hypoxia inducible factor 1 and cAMP response elements. J. Biol. Chem., 270: 21021-21027, 1995.
17. Kaluzová, M., and Kaluz, S. Block-replacement mutagenesis for functional dissection of multiple transcription factor complexes. Biomol. Eng., 18: 9-11, 2001.
18. Stanbridge, E. J. Mycoplasma detection: an obligation to scientific accuracy. Isr. J. Med. Sci., 17: 563-568, 1981.
19. Ray, R., Snyder, R. C., Thomas, S., Koller, C. A., and Miller, D. M. Mithramycin blocks protein binding and function of the SV40 early promoter. J. Clin. Investig., 83: 2003-2007, 1989.
20. Blume, S. W., Snyder, R. C., Ray, R., Thomas, S., Koller, C. A., and Miller, D. M. Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. J. Clin. Investig., 88: 1613-1621, 1991.
21. Opavský, R., Pastoreková S., Zelník, V., Gibadulinová, A., Stanbridge, E. J., Závada, J., Kettmann, R., and Pastorek, J. Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships. Genomics, 33: 480-487, 1996.
22. Blake, M. C., Jambou, R. C., Swick, A. G., Kahn, J. W., and Azizkhan, J. C. Transcriptional initiation is controlled by upstream GC-box interactions in a TATAA-less promoter. Mol. Cell. Biol., 10: 6632-6641, 1990.
23. Pugh, B. F., and Tjian, R. Transcription from a TATA-less promoter requires a multisubunit TFIID complex. Genes Dev., 5: 1935-1945, 1991.
24. Black, A. R., Black, J. D., and Azizkhan-Clifford, J. SP1 and Krüppel-like factor family of transcription factors in cell growth regulation and cancer. J. Cell. Physiol., 188: 143-160, 2001.
25. Ryuto, M., Ono, M., Izumi, H., Yoshida, S., Weich, H. A., Kohno, K., and Kuwano, M. Induction of vascular endothelial factor by tumor necrosis factor α in human glioma cells. J. Biol. Chem., 271: 28220-28228, 1996.
26. Shi, Q., Le, X., Abbruzzese, J. L., Peng, Z., Qian, C-N., Tang, H., Xiong, Q., Wang, B., Li, X-C., and Xie, K. Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma. Cancer Res., 61: 4143-4154, 2001.
27. Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C., and Abraham, J. A. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem., 266: 11947-11954, 1991.
28. Sanchez-Elsner, T., Botella, L. M., Velasco, B., Langa, C., and Bernabeu, C. Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-β pathways. J. Biol. Chem., 277: 43799-43808, 2002.